Graft versus Host Disease (GVHD) Symposium 2012
New Approaches to Graft versus Host Disease Prevention (26:36)
Corey S. Cutler, MD, MPH, FRCPC
Harvard Medical School, Dana-Farber Cancer Institute
Advances in Human Leukocyte Antigen and Effects on GVHD (43:18)
Effie Petersdorf, MD
University of Washington and Fred Hutchinson Cancer Research Center
BAFF and B-cell Subsets: Biologically Relevant Markers for GVHD (42:23)
Stefanie Sarantopoulos, MD, PhD
The University of North Carolina
Lineberger Comprehensive Cancer Center
Stem Cell Graft Sources and GVHD (31:56)
Claudio Anasetti, MD
H. Lee Moffitt Cancer Center and Research Institute
NK Cells and HSCT: Bench to Bedside and Back (42:26)
William J. Murphy, PhD
University of California - Davis
Continuing Medical Education
Release Date: December 1, 2012
Expiration Date: November 30, 2014
Media: Recorded slides and audio presentation. Supplementary educational materials may include downloads of videos, print materials, slides or web pages.
To contact the CME Provider: e-mail firstname.lastname@example.org.
This continuing medical education (CME) program is intended for a community hospital audience including physicians, surgeons and other members of the health care team. Most presentations will benefit primary care physicians in clinical practice. Office managers and administrators may also benefit from awareness and discussion of clinical initiatives and quality management issues.
Global Needs Assessment/Goal Statement
Program content will focus on new information supported by the most recent scientific evidence that affects clinicians and their care of patients. Educational needs will be identified from diverse sources, including data from University Hospitals physician panels and patient care experience related by University Hospitals Home Care services. Support for clinical integration of the health system and performance improvement priorities is the highest priority. Of particular interest will be clinical issues concerning the top ten in-patient DRGs identified in University Hospitals, UH Clinical Council priorities, Joint Commission mandates and Core Measures.
After participating in the activity, participants will be able to:
- Explain the biology of GVHD, the contribution of graft source to its development and what new cellular therapies and biomarkers are being developed for prevention and treatment.
- Review what is known about the development and biology of lung, intestinal track, skin and liver GVHD and discuss current treatment approaches.
- Discuss the signs and symptoms of chronic GVHD, the new classification system and biomarkers of chronic GVHD and novel approaches to prevention and treatment.
This enduring material has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Case Western Reserve University School of Medicine and the Meredith A. Cowden Foundation. Case Western Reserve University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians
Case Western Reserve University School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ for each presentation. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Kenneth R. Cooke, MD, Case Western Reserve University
Dr. Cooke is a speaker for Optum Health and is the PI for two clinical studies for which Amgen provides clinical trial support and study drugs and the CME Program has determined there is no conflict of interest.
Gerald W. Cowden, JD
Partner, Cowden and Humphrey Co. LPA
Mr.Cowden reported no financial interest relevant to this program.
Marti Cowden, Board Member
The Meredith A. Cowden Foundation
Ms.Cowden reported no financial interest relevant to this program.
Matt E. Kalaycio, MD, FACP
Dr.Kalaycio reported no financial interest relevant to this program.
Steven Z. Pavletic, MD, MS
National Institutes of Health Experimental Transplantation and Immunology Branch
Dr. Pavletic reported no financial interest relevant to this program.
Funding for this online activity was made possible through grants from Viracor IBT, Therakos Inc., Athersysc Inc. and The Meredith A. Cowden Foundation. Acceptance of funding in support of this activity does not constitute endorsement of any product or manufacturer.
The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests. Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve University School of Medicine CME Program also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.
To receive a statement of credit for up to 0.75 AMA PRA Category 1 Credit(s)™ you must:
- Review the full content of the recorded session.
- Reflect on the content.
- Successfully complete the post-test. A score of 100% is required.
- Complete the evaluation.
- Print the certificate of credit for your records.
- Your credit will be recorded by the Case School of Medicine CME Program and made a part of your cumulative transcript.
Estimated Time to Complete this Educational Activity
Including review of the supplementary material and completion of the post-test, this activity is expected to take 45 minutes to complete.
There is no fee for this program.
Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The author has checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.
Although every effort is made to ensure that this material is accurate and up-to-date, it is provided for the convenience of the user and should not be considered definitive. Neither the author nor the Case Western Reserve University School of Medicine nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.
Learners are encouraged to confirm the information contained herein with other sources. This information should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians. The Case Western Reserve University School of Medicine will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising here from.
It is the policy of the Case Western Reserve University School of Medicine CME Program to maintain the privacy of patients’ Protected Health Information (PHI) and to abide by all state and federal privacy laws (including the Health Insurance Portability and Accountability Act of 1996 (HIPAA)).
Of specific concern to CME providers are situations where PHI might appear in a presenter’s written educational materials or audio/visual materials. For example, information attributable to a specific patient might be included in a written case study or verbal discussion of a case or might appear in a visual presentation such an x-ray or similar diagnostic image or test where patient identifiers have not been removed.
Accordingly, PHI may not be present in any aspect of an educational presentation without a patient’s written authorization (and such authorization must be HIPAA compliant after April 14, 2003).
Prior to presenting a presenter must represent and warrant that he/she has HIPAA-compliant authorization for any PHI in the presentation or presentation materials or that he/she acquired such protected health information from a source that (a) obtained a HIPAA-compliant authorization which authorizes Presenter's use of PHI during the presentation; or (b) was not under a legal obligation to maintain the patient's confidentiality.
CME Program Confidentiality Policy
It is the intent of the Case Western Reserve University CME Program in conformance with University policies to prevent identity theft to maintain the confidentiality of any physician or healthcare provider information obtained or utilized by the CME Program in the course of registration for CME activities, participation as faculty, preparation and release of transcripts of activities for which credit has been earned, or any other CME Program function that involves confidential information. Such confidential information includes physician mailing address, last four digits only of the Social Security number (used as a unique identifier) and record of credit hours earned.
All such confidential information will be (1) retained in a secure, password-protected electronic data base and filing system, (2) never displayed where it may be observed or recorded and (3) released individually only upon receipt of written authorization from the party requesting their own information.
The sole exception to the above is the use of the last four digits of the Social Security number in printed class lists to assure that participants with identical names are able to appropriately register or sign in.
Flash Player Plugin
Adobe Acrobat Reader
Internet Explorer 5.5 or greater
Netscape 7.02 or greater
Safari and Firefox 1.5 or greater
Windows 98 SE or above
Mac OS X 10.2 or above
© 2012 Case Western Reserve University